Skip to main content

Table 1 YY1 scoring as continuous variable

From: YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma

 

YY1 - 0

YY1 - 1

YY1 - 2

YY1 - 3

YY1 - 4

Clinical features

4 patients

9 patients

4 patients

9 patients

15 patients

Age

16.3 ± 7.4

30.1 ± 23.9

13.0 ± 2.2

12.3 ± 8.9

19.7 ± 13.4

Gender

     

Male

25.0

66.7

100.0

66.0

73.3

Chemonecrosis ≥ 90%

50.0

33.3

25.0

33.3

40.0

Metachronous metastasis (%)*

0

12.5

75.0

60.0

88.9

Mortality

25.0

22.2

50.0

66.7

53.3

Mean follow -up

50.3 ± 31.6

39.7 ± 21.0

62.0 ± 37.3

43.6 ± 23.0

48.5 ± 25.6

  1. *Data reported are from the 27 patients free of metastasis at baseline and expressed in percentage